#United States #New York #Aetna #Health Press #Bausch Health

Weekly Healthcare Highlights

In a week overflowing with important news in the healthcare sector, it can be quite challenging for journalists and consumers to catch up on all the noteworthy press releases. This recap highlights 11 key announcements that are shaping the future of healthcare.

1. Gift of Life Collaborates with Labcorp and DOUBLEMINT®

A groundbreaking initiative has been launched by Gift of Life in partnership with Labcorp and DOUBLEMINT®, aiming to expand the marrow donor registry. By simply chewing a piece of specially designed gum for five minutes, individuals can provide viable samples for HLA typing. This event is set to kick off at Citi Field on August 1, coinciding with a New York Mets game, where hundreds of kits will be distributed to fans.

2. Innovation in Tumor Profiling by Illumina

Illumina has introduced enhancements to its flagship tumor profiling assay. The TSO 500 v2 can assess numerous genes from minute tissue samples, which significantly aids in therapy selection for cancer patients. Early comprehensive genomic profiling shows promising outcomes for personalized treatments, making this a vital development in cancer care.

3. Bausch Health's Strategic Acquisition

Bausch Health has announced its intention to acquire DURECT Corporation in a move aimed at addressing the urgent need for effective treatments for liver disease, specifically alcoholic hepatitis. With the addition of larsucosterol, which has received FDA Breakthrough Therapy Designation, the company is poised to enhance its offerings in the liver treatment domain.

4. Children’s Hospital Colorado and Denver Broncos Foundation Collaborate

Research between Children’s Hospital Colorado and the Denver Broncos Foundation has revealed positive impacts of flag football on female athletes. The study yielded interesting findings, indicating that those participating in flag football report higher energy levels compared to non-athletes, underscoring the dual mental and physical health benefits of sports.

5. MapLight Therapeutics Secures Major Funding

MapLight Therapeutics has announced a successful Series D financing round totaling $372.5 million. The funds will propel its lead program, ML-007C-MA, through ongoing Phase 2 trials focused on treating schizophrenia and Alzheimer's disease-related psychosis.

6. Aetna Introduces New AI Tools

Aetna has rolled out innovative AI and digital tools aimed at enhancing member access and care. With the introduction of Aetna Care Paths, members will receive tailored recommendations and an improved understanding of their healthcare procedures, all available through an easy-to-navigate platform.

7. Strategic Partnerships in Pharma

Hengrui Pharma and GSK have entered into agreements to co-develop up to 12 cutting-edge medicines. This partnership is geared towards Respiratory, Immunology, Inflammation, and Oncology therapies, potentially setting the stage for breakthroughs in several critical health areas.

8. Omni Health Ring Launches EnerQi™

After a successful Kickstarter campaign raising $300,000, Omni Health Ring introduced EnerQi™, a first-of-its-kind dynamic health index. This innovative product evaluates various health factors, including sleep and nutrition, allowing users to monitor their energy levels in real-time.

9. U.S. News Reveals Best Hospitals for 2025-2026

The latest edition of U.S. News Best Hospitals has spotlighted 504 regional hospitals across 49 states, recognized for superior outcomes in patient care. This annual evaluation assists consumers in making informed healthcare choices.

10. ARTBIO Secures Financing for Alpha Radioligand Therapies

ARTBIO has successfully raised $132 million in Series B funding to further its pipeline of Alpha Radioligand therapies. These funds will support clinical trials and expand the company’s manufacturing capabilities.

11. Simtra BioPharma Expands Manufacturing Capacity

Simtra BioPharma Solutions announced a strategic acquisition aimed at enhancing its U.S. manufacturing capacity for injectable medicines. The purchase includes expansive properties that will facilitate the production of oncology-focused therapies at its Bloomington facility.

Each of these announcements sheds light on significant advancements and collaborations in healthcare, emphasizing the dynamic nature of the industry and its commitment to improving patient outcomes. To stay updated on future healthcare news, consider keeping up with PR Newswire’s releases pertaining to health and wellness.